Atlas Private Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-150
Closed -$5K 885
2021
Q1
$5K Buy
150
+56
+60% +$2K ﹤0.01% 621
2020
Q4
$3K Buy
+94
New +$3.25K ﹤0.01% 600

Other funds holding NVO

Atlas Private Wealth Advisors's NVO Position: Q2 2021 in Review

Atlas Private Wealth Advisors sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 150 shares — an estimated $5K sold.

Atlas Private Wealth Advisors first reported a position in NVO in Q4 2020 and held it in 2 quarters. The position peaked at $5K in Q1 2021. 735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

  • Atlas Private Wealth Advisors reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 150 Novo Nordisk shares in Q2 2021, an estimated $5K.
  • Atlas Private Wealth Advisors first reported a position in Novo Nordisk in Q4 2020 and held it in 2 quarters.
  • Atlas Private Wealth Advisors's Novo Nordisk position peaked at $5K in Q1 2021.
  • 735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.